RT @asouth_neph: Better study design and analytic methods, will be up on @NephJC site Inpatient Use of #ACEi and #ARB and Mortality Amo…
RT @tyonarock: ACEI/ARBの使用とCOVID-19の予後との関係 中国からの報告 1128人のCOVID-19陽性高血圧患者 188人ACEI/ARBの使用:3.7%死亡 940人ACEI/ARBの不使用:9.8%死亡 有意差ありという結果 https…
RT @tyonarock: ACEI/ARBの使用とCOVID-19の予後との関係 中国からの報告 1128人のCOVID-19陽性高血圧患者 188人ACEI/ARBの使用:3.7%死亡 940人ACEI/ARBの不使用:9.8%死亡 有意差ありという結果 https…
RT @asouth_neph: Better study design and analytic methods, will be up on @NephJC site Inpatient Use of #ACEi and #ARB and Mortality Amo…
@asouth_neph @MattFrieman @MackayIM Your site is great. And thanks for linking this article earlier: https://t.co/A9x0boB9no
@Barton_options Retrospective review, but decent effect size in terms of absolute and relative risk reduction https://t.co/A9x0boB9no
RT @asouth_neph: Better study design and analytic methods, will be up on @NephJC site Inpatient Use of #ACEi and #ARB and Mortality Amo…
Better study design and analytic methods, will be up on @NephJC site Inpatient Use of #ACEi and #ARB and Mortality Among Patients With Hypertension Hospitalized With COVID-19 | @CircRes h/t @Nephro_Sparks @drjosflynn https://t.co/asc0X7acGP
RT @PLURplus: ACE inhibitors and Angiontensin receptor blockers, decrease death probability in hypertensive COVID19 patients compared to pa…
ACEI/ARBの使用とCOVID-19の予後との関係 中国からの報告 1128人のCOVID-19陽性高血圧患者 188人ACEI/ARBの使用:3.7%死亡 940人ACEI/ARBの不使用:9.8%死亡 有意差ありという結果 https://t.co/ceHzrjzB9s
RT @DanielJDrucker: Association Nation #COVID19 “Lower risk of COVID-19 mortality in patients who received ACEI/ARB versus those who did no…
Pacientes hospitalizados que toman IECAs y ARAs por hipertensión crónica, tiene mejor pronóstico. Mortalidad 3.7 Vs 9.8% https://t.co/DLDSWsv652
Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19 https://t.co/hbSSItpmgO
ACEI/ARB and COVID-19 again, In Circulation AHA, New retrospective multi center study, - 1128 COVID + HTN in chine. - 118 was on ACEI/ARB. - ACEI/ARB compared to other Anti-HTN >> had LOWER mortality. Waiting for more evidence in comparing to non-H
RT @PLURplus: ACE inhibitors and Angiontensin receptor blockers, decrease death probability in hypertensive COVID19 patients compared to pa…
RT @DanielJDrucker: Association Nation #COVID19 “Lower risk of COVID-19 mortality in patients who received ACEI/ARB versus those who did no…
RT @jacabreracardio: 🔹Among hospitalized COVID-19 patients with hypertension, inpatient use of ACEI/ARB was associated with lower risk of a…
Association Nation #COVID19 “Lower risk of COVID-19 mortality in patients who received ACEI/ARB versus those who did not receive ACEI/ARB” https://t.co/SbKwjQvdMG
RT @JaneFreedmanMD: Observational studies have real limitations but it suggests leaving our HTN patients on their meds pending further data
No association of ACE inhibitors and ARBs with mortality in patients with hypertension hospitalized with COVID-19 https://t.co/qFj1WxRuWa
RT @CircRes: Are ACE/ARB inhibitors safe for #COVID19 patients? https://t.co/FGsCthPS24 A new observational study suggests that use of #A…
🔹Among hospitalized COVID-19 patients with hypertension, inpatient use of ACEI/ARB was associated with lower risk of all-cause mortality compared with ACEI/ARB non- users 🔻https://t.co/HZXvab23HI https://t.co/iEMbRqSxxh
RT @RobertLKruse: @csentropy Well, the study has been done, and they did see that ACEI/ARB was associated with lower risk of all-cause mort…
RT @RobertLKruse: @csentropy Well, the study has been done, and they did see that ACEI/ARB was associated with lower risk of all-cause mort…
@csentropy Well, the study has been done, and they did see that ACEI/ARB was associated with lower risk of all-cause mortality compared with non-users. More clinical trials are ongoing to investigate this in a prospective manner. https://t.co/p91aoe6NsJ
RT @CircRes: Are ACE/ARB inhibitors safe for #COVID19 patients? https://t.co/FGsCthPS24 A new observational study suggests that use of #A…
RT @CircRes: Are ACE/ARB inhibitors safe for #COVID19 patients? https://t.co/FGsCthPS24 A new observational study suggests that use of #A…
RT @CircRes: Are ACE/ARB inhibitors safe for #COVID19 patients? https://t.co/FGsCthPS24 A new observational study suggests that use of #A…
RT @CircRes: Are ACE/ARB inhibitors safe for #COVID19 patients? https://t.co/FGsCthPS24 A new observational study suggests that use of #A…
RT @CircRes: Are ACE/ARB inhibitors safe for #COVID19 patients? https://t.co/FGsCthPS24 A new observational study suggests that use of #A…
こちらも。
RT @CircRes: Are ACE/ARB inhibitors safe for #COVID19 patients? https://t.co/FGsCthPS24 A new observational study suggests that use of #A…
RT @CircRes: Are ACE/ARB inhibitors safe for #COVID19 patients? https://t.co/FGsCthPS24 A new observational study suggests that use of #A…
Observational studies have real limitations but it suggests leaving our HTN patients on their meds pending further data
RT @CircRes: Are ACE/ARB inhibitors safe for #COVID19 patients? https://t.co/FGsCthPS24 A new observational study suggests that use of #A…
RT @CircRes: Are ACE/ARB inhibitors safe for #COVID19 patients? https://t.co/FGsCthPS24 A new observational study suggests that use of #A…
Are ACE/ARB inhibitors safe for #COVID19 patients? https://t.co/FGsCthPS24 A new observational study suggests that use of #ACE inhibitors/ARBs is not associated with increased mortality compared to nonusers with hypertension. #AHACOVD19 https://t.co/Sfqe